During the past decade, AZ Sint-Jan conducted 257 clinical trials. In the 10-year time frame, 257 clinical trials started and 92 clinical trials were completed, i.e. on average, 35.8% percent of trials that started reached the finish line to date. In the past 5 years, 131 clinical trials started and 70 clinical trials were completed. i.e. 53.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Sint-Jan" #1 sponsor was "AZ Sint-Jan AV" with 31 trials, followed by "University Hospital, Ghent" with 21 trials sponsored, "Celgene" with 20 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 19 trials sponsored and "The Lymphoma Academic Research Organisation" with 19 trials sponsored. Other sponsors include 263 different institutions and companies that sponsored additional 143 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Sint-Jan" #1 collaborator was "AZ Sint-Jan AV" with 15 trials as a collaborator, "KU Leuven" with 7 trials as a collaborator, "Merck Sharp & Dohme LLC" with 7 trials as a collaborator, "University Ghent" with 7 trials as a collaborator and "University Hospital, Antwerp" with 7 trials as a collaborator. Other collaborators include 253 different institutions and companies that were collaborators in the rest 185 trials.

According to Clinical.Site data, the most researched conditions in "AZ Sint-Jan" are "Atrial Fibrillation" (15 trials), "Leukemia" (14 trials), "Multiple Myeloma" (13 trials), "Myelodysplastic Syndromes" (13 trials) and "Acute Myeloid Leukemia" (11 trials). Many other conditions were trialed in "AZ Sint-Jan" in a lesser frequency.

Most popular intervention types in "AZ Sint-Jan" are "Drug" (244 trials), "Procedure" (53 trials), "Device" (51 trials), "Other" (45 trials) and "Biological" (33 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (61 trials), "Rituximab" (14 trials), "cytarabine" (12 trials), "Lenalidomide" (9 trials) and "radiation therapy" (9 trials). Other intervention names were less common.

The vast majority of trials in "AZ Sint-Jan" are 348 trials for "All" genders, 18 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are 148 active trials in "AZ Sint-Jan". 1 are not yet recruiting, 93 are recruiting, 51 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 170 completed trials in AZ Sint-Jan, undefined suspended trials, and 34 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Sint-Jan, 12 "Phase 1" clinical trials were conducted, 77 "Phase 2" clinical trials and 149 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 32 trials, and there were also 65 trials that are defined as “Not Applicable".

AZ Sint-Jan has several departments that took part in Clinical trials: "AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology" - 4 trials